Scinai Immunotherapeutics Ltd.

SCNI

HealthcareNASDAQIL

$0.4123

-$0.0267 (-6.08%)

SCNI

Analysis Workspace

Estimates, scoring, valuation assumptions, and peer comparison in one research surface.

Consensus

N/A

Quality

B-

3/5

Price Target

N/A

Forward Revenue

$658.0K

Dec 2024

Scinai Immunotherapeutics Ltd. · Forecast overview

Model view

Forward Revenue

$658.0K

Dec 2024

Revenue range

Low: $658.0K

High: $658.0K · Annual

EPS avg

$0.00

Consensus

Analyst coverage

Analysts

Bars show expected revenue while the line tracks expected EPS.

Annual

1 periods

Period	Revenue avg	Revenue range	EBITDA	EPS avg	Analysts
Dec 2024	$658.0K	$658.0K - $658.0K	$394.8K	$0.00	1

Loading analysis workspace